Fred Princen

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: Nestec S.a.. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fred Princen. Retrieved from https://idiyas.com/inventor/fred-princen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 75.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 47(Granted Patents)

Company Filing History:

8 out of 2,371

Nestec S.a.

patents

Years Active: 2014-2019

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10338083 - Pathway specific markers for diagnosing irritable bowel syndrome (2019-07-02),

2. 10184940 - Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for IBS (2019-01-22),

3. 10036759 - Pathway specific markers for diagnosing irritable bowel syndrome (2018-07-31),

4. 9891235 - Pathway specific assays for predicting irritable bowel syndrome diagnosis (2018-02-13),

5. 9739786 - Pathway specific markers for diagnosing irritable bowel syndrome (2017-08-22),

6. 9732385 - Method for determining the risk of crohn's disease-related complications (2017-08-15),

7. 9512482 - Compositions and methods for detecting allelic variants (2016-12-06),

8. 8715943 - Methods for improving inflammatory bowel disease diagnosis (2014-05-06),

Title: Innovations by Fred Princen in Diagnosing Irritable Bowel Syndrome

Introduction

Fred Princen is an accomplished inventor based in La Jolla, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to irritable bowel syndrome (IBS). With a total of 8 patents to his name, Princen's work has the potential to improve the accuracy of IBS diagnoses and treatment decisions.

Latest Patents

Among his latest patents, Princen has developed methods for diagnosing IBS through pathway-specific markers. This invention aids in determining whether an individual has IBS while ruling out conditions such as celiac disease and inflammatory bowel disease (IBD). The methods provide an accurate diagnostic prediction of IBS, which is crucial for guiding treatment decisions. Another notable patent involves the use of antibodies to microbiome, stress factors, and mast cell markers as diagnostic markers for IBS. This invention utilizes a statistical algorithm to differentiate between IBS samples and healthy control samples, further enhancing diagnostic accuracy.

Career Highlights

Fred Princen is currently employed at Nestec S.A., where he continues to innovate in the field of medical diagnostics. His work has garnered attention for its potential to transform how IBS is diagnosed and treated.

Collaborations

Princen collaborates with talented individuals such as Sharat Singh and Fabiyola Selvaraj, contributing to a dynamic research environment that fosters innovation.

Conclusion

Fred Princen's contributions to the field of IBS diagnostics exemplify the impact of innovative thinking in medicine. His patents not only enhance diagnostic accuracy but also pave the way for improved treatment strategies.

Profile summary based on public USPTO records.